Pharmacology · single question

What is the mechanism of action of Humira (adalimumab)?

  1. Inhibits B-cell activation
  2. Inhibits TNF-alpha
  3. Inhibits IL-6 receptor
  4. Blocks T-cell co-stimulation
Show answer and explanation

Correct answer: B. Inhibits TNF-alpha

  • A. B-cell depletion is the mechanism of rituximab (anti-CD20 monoclonal antibody) — not adalimumab.
  • B. ADALIMUMAB (Humira) is a FULLY HUMAN MONOCLONAL ANTIBODY that INHIBITS TNF-ALPHA (tumor necrosis factor-alpha). TNF-alpha is a key pro-inflammatory cytokine in rheumatoid arthritis, Crohn's disease, psoriasis, and other immune-mediated inflammatory diseases. By neutralizing TNF-alpha, adalimumab reduces inflammatory signaling and symptoms.
  • C. IL-6 receptor inhibition is the mechanism of tocilizumab (Actemra) — not adalimumab.
  • D. T-cell co-stimulation blockade is the mechanism of abatacept (Orencia) — not adalimumab.

Practice Pharmacology questions Pharmacology study notes

More Pharmacology practice questions